Literature DB >> 27701902

Motivational interviewing or reminders for glaucoma medication adherence: Results of a multi-site randomised controlled trial.

Paul F Cook1, Sarah J Schmiege1, Steven L Mansberger2, Christina Sheppler2, Jeffrey Kammer3, Timothy Fitzgerald4, Malik Y Kahook5.   

Abstract

OBJECTIVE: Nonadherence reduces glaucoma treatment efficacy. Motivational interviewing (MI) is a well-studied adherence intervention, but has not been tested in glaucoma. Reminder interventions also may improve adherence.
DESIGN: 201 patients with glaucoma or ocular hypertension were urn-randomised to receive MI delivered by an ophthalmic technician (OT), usual care or a minimal behavioural intervention (reminder calls). MAIN OUTCOME MEASURES: Outcomes included electronic monitoring with Medication Event Monitoring System (MEMS) bottles, two self-report adherence measures, patient satisfaction and clinical outcomes. Multilevel modelling was used to test differences in MEMS results by group over time; ANCOVA was used to compare groups on other measures.
RESULTS: Reminder calls increased adherence compared to usual care based on MEMS, p = .005, and self-report, p = .04. MI had a nonsignificant effect but produced higher satisfaction than reminder calls, p = .007. Treatment fidelity was high on most measures, with observable differences in behaviour between groups. All groups had high baseline adherence that limited opportunities for change.
CONCLUSION: Reminder calls, but not MI, led to better adherence than usual care. Although a large literature supports MI, reminder calls might be a cost-effective intervention for patients with high baseline adherence. Replication is needed with less adherent participants.

Entities:  

Keywords:  adherence; glaucoma; motivational interviewing; reminder; treatment satisfaction

Mesh:

Year:  2016        PMID: 27701902      PMCID: PMC5560586          DOI: 10.1080/08870446.2016.1244537

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  34 in total

1.  Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium.

Authors:  Albert J Bellg; Belinda Borrelli; Barbara Resnick; Jacki Hecht; Daryl Sharp Minicucci; Marcia Ory; Gbenga Ogedegbe; Denise Orwig; Denise Ernst; Susan Czajkowski
Journal:  Health Psychol       Date:  2004-09       Impact factor: 4.267

2.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

3.  The role and interpretation of pilot studies in clinical research.

Authors:  Andrew C Leon; Lori L Davis; Helena C Kraemer
Journal:  J Psychiatr Res       Date:  2010-10-28       Impact factor: 4.791

4.  A randomized trial of methods to help clinicians learn motivational interviewing.

Authors:  William R Miller; Carolina E Yahne; Theresa B Moyers; James Martinez; Matthew Pirritano
Journal:  J Consult Clin Psychol       Date:  2004-12

5.  Examples of implementation and evaluation of treatment fidelity in the BCC studies: where we are and where we need to go.

Authors:  Barbara Resnick; Albert J Bellg; Belinda Borrelli; Carol Defrancesco; Rosemary Breger; Jacki Hecht; Daryl L Sharp; Chantal Levesque; Denise Orwig; Denise Ernst; Gbenga Ogedegbe; Susan Czajkowski
Journal:  Ann Behav Med       Date:  2005-04

6.  The Assessment, Monitoring, and Enhancement of Treatment Fidelity In Public Health Clinical Trials.

Authors:  Belinda Borrelli
Journal:  J Public Health Dent       Date:  2011       Impact factor: 1.821

7.  Sometimes you need a reminder: the effects of prompting self-regulation on regulatory processes, learning, and attrition.

Authors:  Traci Sitzmann; Katherine Ely
Journal:  J Appl Psychol       Date:  2010-01

8.  Do adherence rates and glaucomatous visual field progression correlate?

Authors:  Gemma C M Rossi; Gian Maria Pasinetti; Luigia Scudeller; Rosella Radaelli; Paolo Emilio Bianchi
Journal:  Eur J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 2.597

9.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension.

Authors:  Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner
Journal:  Am J Manag Care       Date:  2009-01       Impact factor: 2.229

10.  Motivational interviewing training to promote Head Start children's adherence to oral health care recommendations: results of a program evaluation.

Authors:  Paul F Cook; Gloria Richardson; Anne Wilson
Journal:  J Public Health Dent       Date:  2012-08-08       Impact factor: 1.821

View more
  5 in total

1.  A Glaucoma-Specific Brief Motivational Interviewing Training Program for Ophthalmology Para-professionals: Assessment of Feasibility and Initial Patient Impact.

Authors:  Paula Anne Newman-Casey; Olivia Killeen; Sarah Miller; Chamisa MacKenzie; Leslie M Niziol; Ken Resnicow; John W Creswell; Paul Cook; Michele Heisler
Journal:  Health Commun       Date:  2018-12-20

2.  Whitecoat Adherence in Patients With Primary Open-Angle Glaucoma.

Authors:  Shervonne Poleon; Nouran Sabbagh; Lyne Racette
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.

Authors:  Cecilia N Hollenhorst; Vanessa Elliott; Michele Heisler; Kevin Schneider; Ken Resnicow; Paula Anne Newman-Casey
Journal:  Ophthalmol Glaucoma       Date:  2020-05-07

Review 4.  Outcome measures for adherence data from a medication event monitoring system: A literature review.

Authors:  Linda Hartman; Willem F Lems; Maarten Boers
Journal:  J Clin Pharm Ther       Date:  2018-09-01       Impact factor: 2.512

5.  Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program.

Authors:  David J Miller; Leslie M Niziol; Angela R Elam; Michele Heisler; Paul P Lee; Kenneth Resnicow; David C Musch; Deborah Darnley-Fisch; Jamie Mitchell; Paula Anne Newman-Casey
Journal:  Ophthalmol Glaucoma       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.